EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Revealing the Unseen: Next-Generation Sequencing for Early Detection of Drug-Resistant Cytomegalovirus Variants Upon Letermovir Prophylaxis Failure

Klaudia Nägele, Veronika Bättig, Rainer Gosert, Carla S Walti, Spasenija Savic Prince, Jörg Halter, Roby Mathews, Claudia Stühler, Nina Khanna iD, Karoline Leuzinger iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiae414 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Klaudia Nägele und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Virology. Hauptthemen laut MEDLINE: Cytomegalovirus, Cytomegalovirus Infections, Drug Resistance, Viral, Antiviral Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Clinical Virology Unit, University Hospital Basel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recipients of allogeneic hematopoietic cell transplant, prophylactic management strategies are essential for preventing cytomegalovirus (CMV) reactivation and associated disease. We report on a 63-year-old male patient with a D−/R+ CMV serostatus, who showed ongoing low-level CMV replication after hematopoietic cell transplant despite receiving letermovir prophylaxis. Sanger sequencing failed to detect drug resistance mutations (DRMs) until CMV pneumonitis developed, revealing a UL56-C325R DRM linked to high-level letermovir resistance. Retrospective analysis with next-generation sequencing revealed the DRM at a low frequency of 6% two weeks prior to detection by Sanger sequencing. This study highlights the importance of advanced next-generation sequencing methods for early detection of CMV DRMs, allowing for faster adjustments in antiviral treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusCytomegalovirus InfectionsDrug Resistance, ViralAntiviral AgentsHigh-Throughput Nucleotide SequencingAcetatesQuinazolinesHumansMaleMiddle AgedHematopoietic Stem Cell TransplantationTreatment FailureMutation

Stichwörter der Autor:innen

Sanger sequencingcytomegalovirushematopoietic cell transplantationletermovirnext-generation sequencing

Substanzen

letermovirAntiviral AgentsAcetatesQuinazolines

Autor:innen und Institutionen

  • Clinical Virology.
  • Infectious Diseases and Hospital Epidemiology.
  • Institute of Pathology.
  • Division of Hematology, University Hospital Basel.
  • Infection Biology Laboratory, Department of Biomedicine, University of Basel, Switzerland.

ORCID-Profile: Nina Khanna, Karoline Leuzinger

Förderung

  • Clinical Virology Unit
  • University Hospital Basel

Zitieren

APA

Nägele, K., Bättig, V., Gosert, R., Walti, C. S., Prince, S. S., Halter, J., Mathews, R., Stühler, C., Khanna, N., & Leuzinger, K. (2025). Revealing the Unseen: Next-Generation Sequencing for Early Detection of Drug-Resistant Cytomegalovirus Variants Upon Letermovir Prophylaxis Failure. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae414

Vancouver

Nägele K, Bättig V, Gosert R, Walti CS, Prince SS, Halter J, et al. Revealing the Unseen: Next-Generation Sequencing for Early Detection of Drug-Resistant Cytomegalovirus Variants Upon Letermovir Prophylaxis Failure. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae414

BibTeX
@article{Ngele2025,
  author = {Nägele, Klaudia and Bättig, Veronika and Gosert, Rainer and Walti, Carla S and Prince, Spasenija Savic and Halter, Jörg and Mathews, Roby and Stühler, Claudia and Khanna, Nina and Leuzinger, Karoline},
  title = {Revealing the Unseen: Next-Generation Sequencing for Early Detection of Drug-Resistant Cytomegalovirus Variants Upon Letermovir Prophylaxis Failure},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiae414}
}
Kostenlos starten →